Grantham, Mayo, Van Otterloo & Co (GMO)’s Comerica CMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-423,815
Closed -$36.8M 648
2025
Q4
$36.8M Buy
+423,815
New +$34.1M 0.09% 90
2021
Q2
Sell
-4,100
Closed -$294K 735
2021
Q1
$294K Sell
4,100
-900
-18% -$58.9K ﹤0.01% 784
2020
Q4
$279K Buy
+5,000
New +$244K ﹤0.01% 760
2019
Q1
Sell
-3,000
Closed -$206K 704
2018
Q4
$206K Sell
3,000
-400
-12% -$31.8K ﹤0.01% 509
2018
Q3
$307K Buy
+3,400
New +$324K ﹤0.01% 480
2015
Q4
Sell
-16,727
Closed -$687K 563
2015
Q3
$687K Sell
16,727
-23,773
-59% -$1.08M ﹤0.01% 439
2015
Q2
$2.08M Sell
40,500
-9,200
-19% -$448K 0.01% 320
2015
Q1
$2.24M Buy
49,700
+3,900
+9% +$174K 0.01% 327
2014
Q4
$2.15M Sell
45,800
-7,800
-15% -$366K 0.01% 322
2014
Q3
$2.67M Buy
53,600
+19,100
+55% +$958K 0.01% 326
2014
Q2
$1.73M Sell
34,500
-4,300
-11% -$210K ﹤0.01% 373
2014
Q1
$2.01M Sell
38,800
-5,700
-13% -$274K 0.01% 416
2013
Q4
$2.12M Buy
44,500
+500
+1% +$22K 0.01% 397
2013
Q3
$1.73M Sell
44,000
-4,400
-9% -$183K ﹤0.01% 417
2013
Q2
$1.93M Buy
+48,400
New +$1.81M 0.01% 399

Other funds holding CMA

Grantham, Mayo, Van Otterloo & Co (GMO)'s CMA Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Comerica (CMA) in Q1 2026, closing a stake of 423,815 shares — an estimated $36.8M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CMA in Q2 2013 and held it in 15 quarters. The position peaked at $36.8M in Q4 2025. 4 funds tracked by Wall St. Rank hold CMA as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Comerica position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 423,815 Comerica shares in Q1 2026, an estimated $36.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Comerica in Q2 2013 and held it in 15 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Comerica position peaked at $36.8M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Comerica as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.